What one share of Haemonetics holds
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components.
Haemonetics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-27; the balance sheet is as of 2026-06-27.
| Sales | $28.95 |
|---|---|
| Profit | $2.06 |
| Capex (buildings and equipment) | $0.79 |
| Free cash flow | $6.24 |
| Cash and investments | $4.91 |
| Debt | $25.82 |
| Book value | $18.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $11.42 | $1.13 | $1.08 | $1.15 | — | $10.63 |
| 2010 | $12.38 | $1.12 | $1.08 | $1.43 | — | $11.66 |
| 2011 | $13.22 | $1.56 | $0.91 | $1.50 | — | $13.37 |
| 2012 | $14.11 | $1.30 | $1.03 | $1.20 | — | $14.48 |
| 2013 | $17.07 | $0.74 | $1.19 | $0.44 | — | $15.07 |
| 2014 | $17.92 | $0.67 | $1.41 | $1.26 | — | $16.10 |
| 2015 | $17.48 | $0.32 | $2.35 | $0.10 | — | $15.99 |
| 2016 | $17.85 | −$1.09 | $2.01 | $0.38 | — | $14.17 |
| 2017 | $17.20 | −$0.51 | $1.48 | $1.62 | — | $14.15 |
| 2018 | $16.90 | $0.85 | $1.40 | $2.72 | — | $14.38 |
| 2019 | $18.28 | $1.04 | $2.25 | $0.76 | — | $13.09 |
| 2020 | $19.08 | $1.48 | $0.94 | $2.11 | — | $11.67 |
| 2021 | $16.97 | $1.55 | $0.72 | $1.40 | — | $14.38 |
| 2022 | $19.34 | $0.84 | $1.88 | $1.48 | — | $14.66 |
| 2023 | $22.73 | $2.24 | $3.72 | $1.59 | — | $16.21 |
| 2024 | $25.47 | $2.29 | $0.74 | $2.79 | — | $18.90 |
| 2025 | $26.82 | $3.31 | $0.77 | $2.81 | — | $17.02 |
| 2026 | $28.17 | $2.05 | $0.69 | $5.50 | — | $17.60 |
Common questions about Haemonetics
How much does one share of Haemonetics earn?
Over the last 12 months, each share of Haemonetics earned $2.06 of profit on $28.95 of sales, keeping about 7¢ of every $1 (profit margin).
Does Haemonetics pay a dividend?
Haemonetics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Haemonetics’s book value per share?
Haemonetics’s book value is $18.41 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 27, 2026.
How much cash and debt does each share of Haemonetics have?
Each share of Haemonetics has $4.91 of cash and investments and $25.82 of debt, as of June 27, 2026.
What is Haemonetics’s free cash flow per share?
$6.24 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Haemonetics’s profit per share changed over time?
Profit per share went from $1.13 in 2009 to $2.05 in 2026, growing about 3.6% a year (adjusted for stock splits).
Has Haemonetics bought back shares?
Haemonetics’s share count fell about 10% from 2009 to 2026. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.